Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Stan Kahler CV 2016

1,264 views

Published on

  • Be the first to comment

  • Be the first to like this

Stan Kahler CV 2016

  1. 1. CURRICULUM VITAE STANLEY B. KAHLER, B.A. Clinical Trials Management Resources, LLC 3585 Deer Valley Dr, Castle Rock, CO 80104 Phone 720-270-2309 email: sbkahler66@gmail.com Education Bachelor of Arts Union College Chemistry Lincoln, NE 1989 Experience Clinical Trials Management Resources, LLC 2009-present Clinical Research Coordinator Cedarburg Hauser Pharmaceuticals 2011-2012 Denver, CO Analytical Chemist Anlaytical Services Array Biopharma, Inc. 2006-2009 Longmont, CO Research Associate Analytical Research and Development Mayne Pharma 2005-2006 (formerly Napro Biotherapeutics, now Hospira) Boulder, CO Analytical Chemist Technical Services Group Tapestry Pharmaceuticals 2002-2005 (formerly Napro Biotherapeutics) Boulder, CO Chemist Analytical Development/Chemistry Development Napro Biotherapeutics 2000-2002 Boulder, CO Chemist Analytical Development/Chemistry Development Rosemont Pharmaceuticals 1993-2000 (now Upsher Smith) Analytical Chemist Harris Laboratories 1990-1992 Lincoln, NE Analytical Chemist
  2. 2. Stanley B. Kahler, B.A. Page 2 of 3 Union College, Lincoln, NE 1985-1989 Full time student Investigative Trials Clinical Research Coordinator. A Phase 3, Multi-center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-inflammatory Drugs (NSAIDS ) versus NSAIDS Alone in Patients with Osteoarthritis of the Knee or Hip. Pfizer Inc. Jan 2009-May 2009. Clinical Research Coordinator. A 26 Week, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Single Intra-Articular Injection 1.2% Sodium Hyaluronate for Treatment of Painful Osteoarthritis of the Knee, with Optional 26-Week Open-Label Safety Extension. Ferring International Pharmascience Center, U.S., Inc. August 2009-April 2011. Clinical Research Coordinator. Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO). Ardea Biosciences, Inc. November 2011-May 2013. Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol (CLEAR 1). Ardea Biosciences, Inc. March 2012-September 2014. Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects with Gout who have had an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor (LIGHT). Ardea Biosciences, Inc. March 2012- November 2013 Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Febuxostat Compared to Febuxostat Alone at Lowering Serum Uric Acid and Resolving Tophi in Subjects with Tophaceous Gout (CRYSTAL). Ardea Biosciences, Inc. March 2012-July 2014. Clinical Research Coordinator. A Long-Term Open-Label Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects with Gout. LIGHT Extension Study. Ardea Biosciences, Inc. November 2012-July 2014. Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol. CLEAR Extension Study. Ardea Biosciences, Inc. August 2013-present. Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with Febuxostat for Subjects with Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat. CRYSTAL Extension Study. Ardea Biosciences, Inc. May 2013-present.
  3. 3. Stanley B. Kahler, B.A. Page 3 of 3 Clinical Research Coordinator. A Multi-Center, Randomized, Double-Blind, Phosphate Buffered Saline-Controlled Study to Evaluate Effectiveness and Safety of a Single Intra-Articular Injection of Gel-One® for the Treatment of Osteoarthritis of the Knee with Open-Label Safety Extension. August 2013 - April 2016 Clinical Research Coordinator. A Study to Determine the Presence and Volume of Monosodium Urate Crystals as Assessed by Dual-Energy Computed Tomography in Gout Patients Treated with Allopurinol. May 2015 – March 2016

×